Segments - Schedule of Segment Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Revenues	$ 5,606,914	$ 2,965,171
Cost of sales	(3,697,854)	(2,383,703)
Gross margin	1,909,060	581,468
Operating expenses	6,010,359	3,387,562
Operating income (loss)	(403,445)	(422,391)
Other income (expense)	(8,949,966)	2,677,956
Net income (loss) before income tax	(9,353,411)	2,255,565
Cash and restricted cash	29,005,083		$ 31,235,456
Total assets	108,797,989		107,211,921
Property Development [Member]
Revenues	3,894,131	2,954,389
Cost of sales	(3,614,832)	(2,380,820)
Gross margin	279,299	573,569
Operating expenses	(359,489)	(277,056)
Operating income (loss)	(80,190)	296,513
Other income (expense)	(9,873)	7,539
Net income (loss) before income tax	(90,063)	304,052
Cash and restricted cash	9,842,218		8,150,769
Total assets	30,877,470		28,954,484
Digital Transformation Technology [Member]
Revenues
Cost of sales
Gross margin
Operating expenses	(30,128)	(18,228)
Operating income (loss)	(30,128)	(18,228)
Other income (expense)	(36,471)	(92,477)
Net income (loss) before income tax	(66,599)	(110,705)
Cash and restricted cash	154,738		158,058
Total assets	154,840		158,160
Biohealth Business [Member]
Revenues	1,712,783	10,782
Cost of sales	(83,022)	(2,883)
Gross margin	1,629,761	7,899
Operating expenses	(846,480)	(132,791)
Operating income (loss)	783,281	(124,892)
Other income (expense)	(8,371,117)	193
Net income (loss) before income tax	(7,587,836)	(124,699)
Cash and restricted cash	3,251,622		1,590,265
Total assets	43,241,793		524,603
Other [Member]
Revenues
Cost of sales
Gross margin
Operating expenses	(1,076,408)	(575,784)
Operating income (loss)	(1,076,408)	(575,784)
Other income (expense)	(532,505)	2,762,701
Net income (loss) before income tax	(1,608,913)	$ 2,186,917
Cash and restricted cash	15,756,505		21,336,364
Total assets	$ 34,523,886		$ 77,574,674